Likewise, overall survival analysis of 365 HCC patients (91 with low/medium and 274 with high FOXO3 levels) indicated that individuals overexpressing this factor have significantly lower survival rates (Figure 3b). The gene discussed is FOXO3; the disease is hepatocellular carcinoma.